Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial

BACKGROUND: Breast cancer becomes lethal when visceral metastases develop. At this stage, anti-cancer treatments aim at relieving symptoms and delaying death without resulting in additional toxicity. On the basis of their differential anti-oxidant defence level, tumour cells can be made more sensiti...

Full description

Saved in:
Bibliographic Details
Main Authors: Bougnoux, P, Hajjaji, N, Ferrasson, M N, Giraudeau, B, Couet, C, Le Floch, O
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2009
Subjects:
Clinical Study
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2779856/
https://ncbi.nlm.nih.gov/pubmed/19920822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605441
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items